Application no. and date | 16760627.6 (espacenet) (Federated) (European Patent Register), 20160825 | Patent/reg. no. and date | DK/EP 3340993, 20230614 | Publication date | 20180704 | Priority no. and date | US 201562210031 P, 20150826 | EP pub. no. and date |
EP 3340993 20180704 | Effective date | | Applicant/owner | Regulus Therapeutics Inc., 4224 Campus Point Court, Suite 210
San Diego, CA 92121, US, Board of Regents of the University of Texas System, 210 West 7th Street
Austin, TX 78701, US | Applicant ref. no. | P82574DK01 | Inventor | ANDROSAVICH, John R., 10614 Science Center Drive
San Diego, CA 92121, US, CHAU, B. Nelson, 10614 Science Center Drive
San Diego, CA 92121, US, PATEL, Vishal,
Dallas, Texas 75235, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/713 (2006.01) , A61K 45/06 (2006.01) , A61P 13/12 (2006.01) , A61P 9/12 (2006.01) , C12N 15/113 (2010.01) | Title | FORBINDELSE TIL ANVENDELSE I FREMGANGSMÅDER TIL BEHANDLING AF POLYCYSTISK NYRESYGDOM | Int. application no. | US2016048603 | Int. publication no. | WO2017035319 | Related patent (certificate) | | Status | Rettet DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|